Molecular Breast Imaging (MBI) is a new FDA cleared technology and is emerging as a critical tool in the fight against breast disease.

Breast Cancer is one of the most frequently diagnosed cancers in women. Early detection and improved treatments have resulted in substantial improvements to survival rates worldwide. However, improved methods of earlier detection may improve those rates even further. Molecular Breast Imaging(MBI) is a new FDA cleared technology and is emerging as a critical tool in the fight against breast disease. Molecular Breast Imaging Clinical studies have shown that new breast imaging technology, Molecular Breast Imaging (MBI), can detect three times as many cancers in women who have dense breast patterns on their mamograms.*

Molecular Breast Imaging News articles:

MBI three times as effective as mammo in dense tissue

Molecular breast imaging (MBI) finds three times as many cancers as conventional mammography in women with dense breasts, according to a new study published online in Radiology. This is welcome news, because while mammography continues to be the gold standard for breast cancer screening, its sensitivity has been shown to be reduced in this population.
Researchers at the Mayo Clinic in Rochester, MN, compared the performance of MBI with a dual-head dedicated breast gamma camera to that of mammography in screening women with dense breast tissue. They found… read more

Advances in Molecular Breast Imaging, a new AuntMinnie.com special report on MBI, an exciting new technology in breast imaging.

In these pages you’ll find a comprehensive review of MBI, touching on everything from its viability in today’s cost-conscious breast imaging practice to how it fits into an environment increasingly worried about radiation dose.  Read the report

In conjunction with ProMedica, TRA offers the first and only dedicated Molecular Breast Imaging system in Ohio and Michigan, produced by GammaMedica, Inc.